Terrie Kellmeyer
Vermögen: - $ am 30.06.2026
Vermögen: - $ am 30.06.2026
Terrie Kellmeyer is currently Chief Executive Officer at Anavex Life Sciences Corp., a position starting in 2026.
Former roles include Senior Vice President-Regulatory Affairs at Aardvark Therapeutics, Inc. from 2025 to 2026, Group Vice President-Clinical Development at Acer Therapeutics, Inc., and Head-Global Regulatory Affairs at Madrigal Pharmaceuticals, Inc. Education includes an undergraduate degree from Rochester Institute of Technology and a doctorate from The State University of New York.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 04.05.2026 | 0 ( -.--% ) | - $ | 30.06.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| ANAVEX LIFE SCIENCES CORP. | Vorstandsvorsitzender | 04.05.2026 |
| Unternehmen | Position | Ende |
|---|---|---|
| AARDVARK THERAPEUTICS, INC. | General Counsel | 01.05.2026 |
| ACER THERAPEUTICS INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
| MADRIGAL PHARMACEUTICALS, INC. | General Counsel | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 6 |
|---|---|
Rochester Institute of Technology
Rochester Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The State University of New York
The State University of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Anavex Life Sciences Corp.
Anavex Life Sciences Corp. BiotechnologyHealth Technology Engages in the development of innovative drug compounds | Health Technology |
Madrigal Pharmaceuticals, Inc.
Madrigal Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops small-molecule drugs for cardiovascular, metabolic and liver diseases | Health Technology |
Acer Therapeutics, Inc.
Acer Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops and commercializes therapies for serious rare and life-threatening diseases | Health Technology |
Aardvark Therapeutics, Inc.
Aardvark Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel small molecule therapeutics for obesity and metabolic diseases | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen